|
|
|
|
| LEADER |
01619nam a2200337Ia 4500 |
| 001 |
10-3949-ccjm-89a-21031 |
| 008 |
220420s2022 CNT 000 0 und d |
| 020 |
|
|
|a 08911150 (ISSN)
|
| 245 |
1 |
0 |
|a Clinical impact of 2020 American Heart Association statement on menopause and cardiovascular disease risk
|
| 260 |
|
0 |
|b Cleveland Clinic Educational Foundation
|c 2022
|
| 300 |
|
|
|a 5
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3949/ccjm.89a.21031
|
| 520 |
3 |
|
|a The American Heart Association published a 2020 scientific statement on cardiovascular disease risk for women transitioning through or experiencing menopause. The report reflects scientific evidence on menopause and cardiovascular risks, and this article reviews the statement with a focus on what is new and what is clinically important for healthcare providers treating this patient population. © 2022. All Rights Reserved.
|
| 650 |
0 |
4 |
|a American Heart Association
|
| 650 |
0 |
4 |
|a cardiovascular disease
|
| 650 |
0 |
4 |
|a Cardiovascular Diseases
|
| 650 |
0 |
4 |
|a female
|
| 650 |
0 |
4 |
|a Female
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a independent of chronological and ovarian aging
|
| 650 |
0 |
4 |
|a leads to increased cardiovascular risk and mortality
|
| 650 |
0 |
4 |
|a medical society
|
| 650 |
0 |
4 |
|a menopause
|
| 650 |
0 |
4 |
|a Menopause
|
| 650 |
0 |
4 |
|a The American Heart Association 2020 scientific statement supports the notion that the transition of menopause itself
|
| 650 |
0 |
4 |
|a United States
|
| 650 |
0 |
4 |
|a United States
|
| 700 |
1 |
0 |
|a Hirsch, H.
|e author
|
| 700 |
1 |
0 |
|a Iyer, T.K.
|e author
|
| 773 |
|
|
|t Cleveland Clinic Journal of Medicine
|
